Addressing hot topics in general practice: Meningococcal B vaccination - Australian College of Rural and Remote Medicine
Invasive meningococcal disease (IMD) is responsible for serious morbidity and mortality with global estimates of 50,000-135,000 deaths annually. Due to the early non-specific symptoms of IMD, misdiagnosis is common and often results in late medical intervention. Despite the availability of antibiotic therapy, case fatality rate for IMD serogroups B and C among Australian children below 5 years of age is 5%; and 6-12% for adults over the age of 25. Moreover approximately 10-30% of people who survive IMD develop long-term consequences such as limb deformity, limb scarring, deafness and neurological deficits. In this program GPs can update their IMD awareness so that they are more familiar with which variants of IMD are prevalent, how to diagnose it, how to recommend vaccinations and make sure all at risk groups are covered with immunisations.
This online CME event is an Accredited Distance/Remote based education module as defined by the Professional Development Program of the Australian College of Rural and Remote Medicine. ACRRM member participation and information will be noted and sent directly to the ACRRM for accreditation processing. Please allow 30 days for ACRRM to send you your points. This activity is approved for 4PRPD Points.
Robina Town Centre Medical Centre, QLD
Professor Robert Booy
MBBS (Hons), MSc, MD, FRACP, FRCPCH
Head, Clinical Research
National Centre for Immunisation Research and Surveillance
Westmead Children’s Hospital